The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation

Human Reproduction

Volumn 27, Issue 7, 2012, Pages 2010-2019

  Mariani, Margherita ^a   Vigan, Paola ^a   Gentilini, Davide ^b   Camisa, Barbara ^a   Caporizzo, Elvira ^a   Di Lucia, Pietro ^a   Monno, Antonella ^a   Candiani, Massimo ^a   Somigliana, Edgardo ^c   Panina Bordignon, Paola ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

endometriosis; inflammation; vitamin D receptor agonist

Indexed keywords

COLLAGEN; ELOCALCITOL; ESTRADIOL; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VITAMIN D RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL ADHESION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOMETRIOSIS; ENDOMETRIUM CELL; ESTRADIOL BLOOD LEVEL; FEMALE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PERITONITIS; PROTEIN EXPRESSION; REVIEW; TREATMENT RESPONSE;

MUS; PRIMATES;

EID: 84863583379     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/des150     Document Type: Review

References (44)

1. Adorini L. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol 2002;7:1017-1028. (Pubitemid 34756392)
2. Adorini L. Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cell Immunol 2005;2:115-124. (Pubitemid 41074064)
3. Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008;8:404-412.
4. Adorini L, Penna G, Amuchastegui S, Cossetti C, Aquilano F, Mariani R, Fibbi B, Morelli A, Uskokovic M, Colli E et al. Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL-628 (elocalcitol). J Steroid Biochem Mol Biol 2007;103:689-693. (Pubitemid 46401347)
5. Allavena P, Garlanda C, Borrello MG, Sica A, Mantovani A. Pathways connecting inflammation and cancer. Curr Opin Genet Dev 2008;1:3-10. (Pubitemid 351694444)
6. Alroy I, Towers TL, Freedman LP. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 1995;10:5789-5799.
7. Bacci M, Capobianco A, Monno A, Cottone L, Di Puppo F, Camisa B, Mariani M, Brignole C, Ponzoni M, Ferrari S et al. Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol 2009;2:547-556.
8. Brunelli S, Rovere-Querini P. The immune system and the repair of skeletal muscle. Pharmacol Res 2008;2:117-121.
9. Bulun SE. Endometriosis. N Engl J Med 2009;3:268-279.
10. Carlberg C. Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands. Recent Results Cancer Res 2003;164:29-42.
11. Cippitelli M, Santoni A. Vitamin D3: a transcriptional modulator of the interferon-gamma gene. Eur J Immunol 1998;10:3017-3030. (Pubitemid 28470247)
12. Colli E, Rigatti P, Montorsi F, Artibani W, Petta S, Mondaini N, Scarpa R, Usai P, Olivieri L, Maggi M. BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial. Eur Urol 2006;1:82-86. (Pubitemid 41789960)
13. D'Hooghe TM, Kyama CM, Chai D, Fassbender A, Vodolazkaia A, Bokor A, Mwenda JM. Nonhuman primate models for translational research in endometriosis. Reprod Sci 2009;2:152-161.
14. Gentilini D, Busacca M, Di Francesco S, Vignali M, Vigano P, Di Blasio AM. PI3K/Akt and ERK1/2 signalling pathways are involved in endometrial cell migration induced by 17beta-estradiol and growth factors. Mol Hum Reprod 2007;13:317-322. (Pubitemid 47061642)
15. Giarratana N, Penna G, Amuchastegui S, Mariani R, Daniel KC, Adorini L. A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. J Immunol 2004;4:2280-2287. (Pubitemid 39063083)
16. Giudice LC, Kao LC. Endometriosis. Lancet 2004;9447:1789-1799. (Pubitemid 39488065)
17. Gonzalez-Ramos R, Van Langendonckt A, Defrere S, Lousse JC, Mettlen M, Guillet A, Donnez J. Agents blocking the nuclear factor-kappaB pathway are effective inhibitors of endometriosis in an in vivo experimental model. Gynecol Obstet Invest 2008;3:174-186. (Pubitemid 351562920)
18. Griffin MD, Xing N, Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr 2003; 23:117-145. (Pubitemid 37059719)
19. Guo SW. Nuclear factor-kappab (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large? Gynecol Obstet Invest 2007;2:71-97.
20. Guo SW, Hummelshoj L, Olive DL, Bulun SE, D'Hooghe TM, Evers JL. A call for more transparency of registered clinical trials on endometriosis. Hum Reprod 2009;6:1247-1254.
21. Helming L, Bose J, Ehrchen J, Schiebe S, Frahm T, Geffers R, Probst-Kepper M, Balling R, Lengeling A. 1alpha, 25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood 2005;13:4351-4358. (Pubitemid 41775947)
22. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;6(Suppl):1678S-1688S.
23. Holick MF. Vitamin D deficiency. N Engl J Med 2007;3:266-281.
24. Koeffler HP, Amatruda T, Ikekawa N, Kobayashi Y, DeLuca HF. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1, 25-dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res 1984;12(Pt 1):5624-5628. (Pubitemid 15183567)
25. Kwiecinksi GG, Petrie GI, DeLuca HF. 1, 25-Dihydroxyvitamin D3 restores fertility of vitamin D-deficient female rats. Am J Physiol 1989;4(Pt 1):E483-E487.
26. Kyama CM, Debrock S, Mwenda JM, D'Hooghe TM. Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol 2003;1:123.
27. Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertil Steril 2001;1:1-10. (Pubitemid 32041217)
28. Liu PT, Stenger S, LiH, Wenzel L, Tan BH, Krutzik SR, OchoaMT, Schauber J, WuK, Meinken C et al. Toll-like receptor triggering of a vitaminD-mediated human antimicrobial response. Science 2006;5768:1770-1773.
29. Lousse JC, Van Langendonckt A, Gonzalez-Ramos R, Defrere S, Renkin E, Donnez J. Increased activation of nuclear factor-kappa B (NF-kappaB) in isolated peritoneal macrophages of patients with endometriosis. Fertil Steril 2008;1:217-220. (Pubitemid 351885195)
30. Mattner F, Smiroldo S, Galbiati F, Muller M, Di Lucia P, Poliani PL, Martino G, Panina-Bordignon P, Adorini L. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1, 25-dihydroxyvitamin D(3). Eur J Immunol 2000;2:498-508. (Pubitemid 30098842)
31. Minici F, Tiberi F, Tropea A, Orlando M, Gangale MF, Romani F, Campo S, Bompiani A, Lanzone A, Apa R. Endometriosis and human infertility: a new investigation into the role of eutopic endometrium. Hum Reprod 2008;3:530-537. (Pubitemid 351651209)
32. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005;5:662-687. (Pubitemid 41127276)
33. Nap AW, Groothuis PG, Demir AY, Evers JL, Dunselman GA. Pathogenesis of endometriosis. Best Pract Res Clin Obstet Gynaecol 2004;2:233-244. (Pubitemid 38786630)
34. Rossi G, Somigliana E, Moschetta M, Santorsola R, Cozzolino S, Filardo P, Salmaso A, Zingrillo B. Dynamic aspects of endometriosis in a mouse model through analysis of implantation and progression. Arch Gynecol Obstet 2000;3:102-107. (Pubitemid 30153702)
35. Shakiba K, Bena JF, McGill KM, Minger J, Falcone T. Surgical treatment of endometriosis: a 7-year follow-up on the requirement for further surgery. Obstet Gynecol 2008;6:1285-1292.
36. Shand AW, Nassar N, Von Dadelszen P, Innis SM, Green TJ. Maternal vitamin D status in pregnancy and adverse pregnancy outcomes in a group at high risk for pre-eclampsia. BJOG 2010;13:1593-1598.
37. Sharpe-Timms KL. Endometrial anomalies in women with endometriosis. Ann N Y Acad Sci 2001;943:131-147. (Pubitemid 32928309)
38. Somigliana E, Vigano P, Rossi G, Carinelli S, Vignali M, Panina-Bordignon P. Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis. Hum Reprod 1999; 12:2944-2950.
39. Timmer AM, Nizet V. IKKbeta/NF-kappaB and the miscreant macrophage. J Exp Med 2008;6:1255-1259.
40. Tirado-González I, Barrientos G, Tariverdian N, Arck PC, Garcia MG, Klapp BF, Blois SM. Endometriosis research: animal models for the study of a complex disease. J Reprod Immunol 2010;2:141-147.
41. van Kaam KJ, Schouten JP, Nap AW, Dunselman GA, Groothuis PG. Fibromuscular differentiation in deeply infiltrating endometriosis is a reaction of resident fibroblasts to the presence of ectopic endometrium. Hum Reprod 2008;12:2692-2700.
42. Vercellini P, Crosignani P, Somigliana E, Vigano P, Frattaruolo MP, Fedele L. 'Waiting for Godot': a commonsense approach to the medical treatment of endometriosis. Hum Reprod 2011;26:3-13.
43. Vigano P, Lattuada D, Mangioni S, Ermellino L, Vignali M, Caporizzo E, Panina-Bordignon P, Besozzi M, Di Blasio AM. Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. J Mol Endocrinol 2006;3:415-424. (Pubitemid 43904937)
44. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Arioka K, Sato H, Uchiyama Y et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 1997; 4:391-396. (Pubitemid 27323308)